Kantonsspital St.Gallen


Jolijn Smolders & Stephan Brand

abstract A Phase 3 Multicenter, Long-Term Extension Study
to Evaluate the Safety and Efficacy of Upadacitinib
(ABT-494) in Subjects with Ulcerative Colitis
type of project clinical studies
status ongoing - follow up
start of project 2017
end of project 2022
responsible person Prof. Dr. Stephan Brand